Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)

NCT02336230 ·Status: COMPLETED ·Phase: PHASE3

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

NCT01323920 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

NCT01530256 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578 ·Status: COMPLETED ·Phase: PHASE1

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

NCT02133924 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease

NCT00815919 ·Status: COMPLETED ·Phase: PHASE2

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424 ·Status: RECRUITING ·Phase: PHASE2

Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

NCT02652130 ·Status: COMPLETED ·Phase: PHASE3

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

NCT00759018 ·Status: NO_LONGER_AVAILABLE

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant

NCT02684162 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)

NCT01607580 ·Status: COMPLETED ·Phase: NA

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

NCT00186628 ·Status: COMPLETED ·Phase: PHASE2

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

NCT00004878 ·Status: WITHDRAWN ·Phase: PHASE2

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985 ·Status: COMPLETED ·Phase: PHASE2

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

NCT00253552 ·Status: TERMINATED ·Phase: NA

Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD

NCT06133192 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

NCT02728895 ·Status: COMPLETED ·Phase: PHASE1

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

NCT06529731 ·Status: RECRUITING ·Phase: PHASE2

Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

NCT00929695 ·Status: COMPLETED ·Phase: PHASE3

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

NCT02824653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation

NCT01086735 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

NCT00001830 ·Status: COMPLETED ·Phase: PHASE1

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

NCT00117702 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

NCT00096161 ·Status: COMPLETED ·Phase: PHASE2